CompletedPhase 2/3

Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients

Egypt30 participantsStarted 2021-10-10

Plain-language summary

Effect of pre-emptive intravenous immunoglobulin administration on the incidence of septic episodes in pediatric burn patients: A randomized controlled study.

Who can participate

Age range1 Year – 5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All burn patients 1 to 5 years old with 10% or greater burn area of TBSA . Exclusion Criteria: * Patients with septic shock (evidence of infection and inotropes) . * Burns more than 48 hours duration.

What they're measuring

Incidence of sepsis during ICU stay will be recorded.

Timeframe: Through out study completion, average 30 days.

Trial details

NCT IDNCT05134792

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-16

View on ClinicalTrials.gov More Burn Shock trials